PRME logo

Prime Medicine (PRME) Cash From Operations

Annual CFO

-$122.86 M
+$42.55 M+25.72%

December 31, 2024


Summary


Performance

PRME Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRMEcash flowmetrics:

Quarterly CFO

$16.25 M
+$42.16 M+162.69%

December 31, 2024


Summary


Performance

PRME Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRMEcash flowmetrics:

TTM CFO

-$122.86 M
+$60.11 M+32.85%

December 31, 2024


Summary


Performance

PRME TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRMEcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

PRME Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+25.7%+124.0%-10.1%
3 y3 years-260.5%+124.0%-10.1%
5 y5 years-2116.2%+124.0%-10.1%

PRME Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-260.5%+25.7%at high+124.0%-831.7%+32.9%
5 y5-year-2116.2%+25.7%at high+124.0%-9110.3%+32.9%
alltimeall time-2116.2%+25.7%at high+124.0%-9110.3%+32.9%

Prime Medicine Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$122.86 M(-25.7%)
$16.25 M(-162.7%)
-$122.86 M(-32.9%)
Sep 2024
-
-$25.91 M(-43.0%)
-$182.97 M(+16.5%)
Jun 2024
-
-$45.49 M(-32.8%)
-$157.06 M(+40.8%)
Mar 2024
-
-$67.71 M(+54.4%)
-$111.57 M(+154.4%)
Dec 2023
-$165.41 M(+25.5%)
-$43.86 M(+45.7%)
-$43.86 M(-61.6%)
Dec 2022
-$131.83 M
-
-
DateAnnualQuarterlyTTM
Sep 2022
-
-$30.10 M(+48.8%)
-$114.30 M(+35.7%)
Jun 2022
-
-$20.22 M(-60.2%)
-$84.20 M(+31.6%)
Mar 2022
-
-$50.79 M(+285.2%)
-$63.98 M(+385.2%)
Dec 2021
-$34.08 M(+514.8%)
-$13.19 M(+888.5%)
-$13.19 M(+888.5%)
Dec 2020
-$5.54 M
-
-
Dec 2019
-
-$1.33 M
-$1.33 M

FAQ

  • What is Prime Medicine annual cash flow from operations?
  • What is the all time high annual CFO for Prime Medicine?
  • What is Prime Medicine annual CFO year-on-year change?
  • What is Prime Medicine quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Prime Medicine?
  • What is Prime Medicine quarterly CFO year-on-year change?
  • What is Prime Medicine TTM cash flow from operations?
  • What is the all time high TTM CFO for Prime Medicine?
  • What is Prime Medicine TTM CFO year-on-year change?

What is Prime Medicine annual cash flow from operations?

The current annual CFO of PRME is -$122.86 M

What is the all time high annual CFO for Prime Medicine?

Prime Medicine all-time high annual cash flow from operations is -$5.54 M

What is Prime Medicine annual CFO year-on-year change?

Over the past year, PRME annual cash flow from operations has changed by +$42.55 M (+25.72%)

What is Prime Medicine quarterly cash flow from operations?

The current quarterly CFO of PRME is $16.25 M

What is the all time high quarterly CFO for Prime Medicine?

Prime Medicine all-time high quarterly cash flow from operations is $16.25 M

What is Prime Medicine quarterly CFO year-on-year change?

Over the past year, PRME quarterly cash flow from operations has changed by +$83.95 M (+123.99%)

What is Prime Medicine TTM cash flow from operations?

The current TTM CFO of PRME is -$122.86 M

What is the all time high TTM CFO for Prime Medicine?

Prime Medicine all-time high TTM cash flow from operations is -$1.33 M

What is Prime Medicine TTM CFO year-on-year change?

Over the past year, PRME TTM cash flow from operations has changed by -$11.29 M (-10.12%)